 | • レポートコード：D0GIR-12051 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、吸入コルチコステロイドの世界市場を広く調査・分析し、今後の市場展望をまとめております。吸入コルチコステロイドの種類別市場規模（ベクロメタゾンジプロピオネート、ブデソニド、フルチカゾン吸入パウダー、モメタゾン、その他）、用途別市場規模（病院、クリニック、呼吸器ケアセンター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sumitomo、AstraZeneca、Merck、Pfizer、GSK、Novartis、Glaxo's Advair、Johnson and Johnson、Sanofi、Teijin、Amgen、Kos Pharmaceutical、Teva Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・吸入コルチコステロイドの北米市場（アメリカ、カナダ、メキシコ） ・吸入コルチコステロイドのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・吸入コルチコステロイドのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・吸入コルチコステロイドの南米市場（ブラジル、アルゼンチン） ・吸入コルチコステロイドの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ベクロメタゾンジプロピオネート、ブデソニド、フルチカゾン吸入パウダー、モメタゾン、その他 ・用途別分析：病院、クリニック、呼吸器ケアセンター、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Inhaled Corticosteroid market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Inhaled Corticosteroid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Inhaled Corticosteroid market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Inhaled Corticosteroid market has been segmented into
Beclomethasone Dipropionate
Budesonide
Fluticasone Inhaler Powder
Mometasone
Others
By Application, Inhaled Corticosteroid has been segmented into:
Hospitals
Clinics
Respiratory Care Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Inhaled Corticosteroid market presented in the report. This section sheds light on the sales growth of different regional and country-level Inhaled Corticosteroid markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Inhaled Corticosteroid market.
The report offers in-depth assessment of the growth and other aspects of the Inhaled Corticosteroid market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Inhaled Corticosteroid Market Share Analysis
Inhaled Corticosteroid competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Inhaled Corticosteroid sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Inhaled Corticosteroid sales, revenue and market share for each player covered in this report.
The major players covered in Inhaled Corticosteroid are:
Sumitomo
AstraZeneca
Merck
Pfizer
GSK
Novartis
Glaxo’s Advair
Johnson and Johnson
Sanofi
Teijin
Amgen
Kos Pharmaceutical
Teva Pharmaceutical
Among other players domestic and global, Inhaled Corticosteroid market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhaled Corticosteroid product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inhaled Corticosteroid, with price, sales, revenue and global market share of Inhaled Corticosteroid in 2018 and 2019.
Chapter 3, the Inhaled Corticosteroid competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhaled Corticosteroid breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Inhaled Corticosteroid market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Inhaled Corticosteroid sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Inhaled Corticosteroid Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inhaled Corticosteroid Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Beclomethasone Dipropionate
1.2.3 Budesonide
1.2.4 Fluticasone Inhaler Powder
1.2.5 Mometasone
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Inhaled Corticosteroid Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Respiratory Care Centers
1.3.5 Others
1.4 Overview of Global Inhaled Corticosteroid Market
1.4.1 Global Inhaled Corticosteroid Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sumitomo
2.1.1 Sumitomo Details
2.1.2 Sumitomo Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sumitomo SWOT Analysis
2.1.4 Sumitomo Product and Services
2.1.5 Sumitomo Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AstraZeneca SWOT Analysis
2.2.4 AstraZeneca Product and Services
2.2.5 AstraZeneca Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GSK SWOT Analysis
2.5.4 GSK Product and Services
2.5.5 GSK Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Glaxo’s Advair
2.7.1 Glaxo’s Advair Details
2.7.2 Glaxo’s Advair Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Glaxo’s Advair SWOT Analysis
2.7.4 Glaxo’s Advair Product and Services
2.7.5 Glaxo’s Advair Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson and Johnson
2.8.1 Johnson and Johnson Details
2.8.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson and Johnson SWOT Analysis
2.8.4 Johnson and Johnson Product and Services
2.8.5 Johnson and Johnson Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi SWOT Analysis
2.9.4 Sanofi Product and Services
2.9.5 Sanofi Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teijin
2.10.1 Teijin Details
2.10.2 Teijin Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Teijin SWOT Analysis
2.10.4 Teijin Product and Services
2.10.5 Teijin Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Amgen
2.11.1 Amgen Details
2.11.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Amgen SWOT Analysis
2.11.4 Amgen Product and Services
2.11.5 Amgen Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Kos Pharmaceutical
2.12.1 Kos Pharmaceutical Details
2.12.2 Kos Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Kos Pharmaceutical SWOT Analysis
2.12.4 Kos Pharmaceutical Product and Services
2.12.5 Kos Pharmaceutical Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Teva Pharmaceutical
2.13.1 Teva Pharmaceutical Details
2.13.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Teva Pharmaceutical SWOT Analysis
2.13.4 Teva Pharmaceutical Product and Services
2.13.5 Teva Pharmaceutical Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Inhaled Corticosteroid Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Inhaled Corticosteroid Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Inhaled Corticosteroid Manufacturer Market Share in 2019
3.3.2 Top 6 Inhaled Corticosteroid Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Inhaled Corticosteroid Sales, Revenue and Market Share by Regions
4.1.1 Global Inhaled Corticosteroid Sales and Market Share by Regions (2015-2020)
4.1.2 Global Inhaled Corticosteroid Revenue and Market Share by Regions (2015-2020)
4.2 North America Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
4.3 Europe Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
4.5 South America Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Inhaled Corticosteroid Sales, Revenue and Market Share by Country
5.1.1 North America Inhaled Corticosteroid Sales and Market Share by Country (2015-2020)
5.1.2 North America Inhaled Corticosteroid Revenue and Market Share by Country (2015-2020)
5.2 United States Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
5.3 Canada Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
5.4 Mexico Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Inhaled Corticosteroid Sales, Revenue and Market Share by Country
6.1.1 Europe Inhaled Corticosteroid Sales and Market Share by Country (2015-2020)
6.1.2 Europe Inhaled Corticosteroid Revenue and Market Share by Country (2015-2020)
6.2 Germany Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
6.3 UK Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
6.4 France Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
6.5 Russia Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
6.6 Italy Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Inhaled Corticosteroid Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Inhaled Corticosteroid Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Inhaled Corticosteroid Revenue and Market Share by Regions (2015-2020)
7.2 China Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
7.3 Japan Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
7.4 Korea Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
7.5 India Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
7.7 Australia Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Inhaled Corticosteroid Sales, Revenue and Market Share by Country
8.1.1 South America Inhaled Corticosteroid Sales and Market Share by Country (2015-2020)
8.1.2 South America Inhaled Corticosteroid Revenue and Market Share by Country (2015-2020)
8.2 Brazil Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
8.3 Argentina Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Inhaled Corticosteroid Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Inhaled Corticosteroid Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Inhaled Corticosteroid Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
9.3 Turkey Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
9.4 Egypt Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
9.5 South Africa Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Inhaled Corticosteroid Sales and Market Share by Type (2015-2020)
10.2 Global Inhaled Corticosteroid Revenue and Market Share by Type (2015-2020)
10.3 Global Inhaled Corticosteroid Price by Type (2015-2020)
11 Global Inhaled Corticosteroid Market Segment by Application
11.1 Global Inhaled Corticosteroid Sales Market Share by Application (2015-2020)
11.2 Global Inhaled Corticosteroid Revenue Market Share by Application (2015-2020)
11.3 Global Inhaled Corticosteroid Price by Application (2015-2020)
12 Market Forecast
12.1 Global Inhaled Corticosteroid Sales, Revenue and Growth Rate (2021-2025)
12.2 Inhaled Corticosteroid Market Forecast by Regions (2021-2025)
12.2.1 North America Inhaled Corticosteroid Market Forecast (2021-2025)
12.2.2 Europe Inhaled Corticosteroid Market Forecast (2021-2025)
12.2.3 Asia-Pacific Inhaled Corticosteroid Market Forecast (2021-2025)
12.2.4 South America Inhaled Corticosteroid Market Forecast (2021-2025)
12.2.5 Middle East & Africa Inhaled Corticosteroid Market Forecast (2021-2025)
12.3 Inhaled Corticosteroid Market Forecast by Type (2021-2025)
12.3.1 Global Inhaled Corticosteroid Sales Forecast by Type (2021-2025)
12.3.2 Global Inhaled Corticosteroid Market Share Forecast by Type (2021-2025)
12.4 Inhaled Corticosteroid Market Forecast by Application (2021-2025)
12.4.1 Global Inhaled Corticosteroid Sales Forecast by Application (2021-2025)
12.4.2 Global Inhaled Corticosteroid Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Inhaled Corticosteroid Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Inhaled Corticosteroid by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Inhaled Corticosteroid Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sumitomo Basic Information, Manufacturing Base and Competitors
Table 8. Sumitomo Inhaled Corticosteroid Major Business
Table 9. Sumitomo Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 10. Sumitomo SWOT Analysis
Table 11. Sumitomo Inhaled Corticosteroid Product and Services
Table 12. Sumitomo Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Inhaled Corticosteroid Major Business
Table 15. AstraZeneca Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 16. AstraZeneca SWOT Analysis
Table 17. AstraZeneca Inhaled Corticosteroid Product and Services
Table 18. AstraZeneca Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Inhaled Corticosteroid Major Business
Table 21. Merck Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 22. Merck SWOT Analysis
Table 23. Merck Inhaled Corticosteroid Product and Services
Table 24. Merck Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Inhaled Corticosteroid Major Business
Table 27. Pfizer Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Inhaled Corticosteroid Product and Services
Table 30. Pfizer Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. GSK Basic Information, Manufacturing Base and Competitors
Table 32. GSK Inhaled Corticosteroid Major Business
Table 33. GSK Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 34. GSK SWOT Analysis
Table 35. GSK Inhaled Corticosteroid Product and Services
Table 36. GSK Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis Basic Information, Manufacturing Base and Competitors
Table 38. Novartis Inhaled Corticosteroid Major Business
Table 39. Novartis Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 40. Novartis SWOT Analysis
Table 41. Novartis Inhaled Corticosteroid Product and Services
Table 42. Novartis Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Glaxo's Advair Basic Information, Manufacturing Base and Competitors
Table 44. Glaxo's Advair Inhaled Corticosteroid Major Business
Table 45. Glaxo's Advair Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 46. Glaxo's Advair SWOT Analysis
Table 47. Glaxo's Advair Inhaled Corticosteroid Product and Services
Table 48. Glaxo's Advair Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 50. Johnson and Johnson Inhaled Corticosteroid Major Business
Table 51. Johnson and Johnson Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 52. Johnson and Johnson SWOT Analysis
Table 53. Johnson and Johnson Inhaled Corticosteroid Product and Services
Table 54. Johnson and Johnson Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sanofi Basic Information, Manufacturing Base and Competitors
Table 56. Sanofi Inhaled Corticosteroid Major Business
Table 57. Sanofi Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 58. Sanofi SWOT Analysis
Table 59. Sanofi Inhaled Corticosteroid Product and Services
Table 60. Sanofi Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Teijin Basic Information, Manufacturing Base and Competitors
Table 62. Teijin Inhaled Corticosteroid Major Business
Table 63. Teijin Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 64. Teijin SWOT Analysis
Table 65. Teijin Inhaled Corticosteroid Product and Services
Table 66. Teijin Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Inhaled Corticosteroid Major Business
Table 69. Amgen Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 70. Amgen SWOT Analysis
Table 71. Amgen Inhaled Corticosteroid Product and Services
Table 72. Amgen Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Kos Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Kos Pharmaceutical Inhaled Corticosteroid Major Business
Table 75. Kos Pharmaceutical Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 76. Kos Pharmaceutical SWOT Analysis
Table 77. Kos Pharmaceutical Inhaled Corticosteroid Product and Services
Table 78. Kos Pharmaceutical Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Teva Pharmaceutical Inhaled Corticosteroid Major Business
Table 81. Teva Pharmaceutical Inhaled Corticosteroid Total Revenue (USD Million) (2018-2019)
Table 82. Teva Pharmaceutical SWOT Analysis
Table 83. Teva Pharmaceutical Inhaled Corticosteroid Product and Services
Table 84. Teva Pharmaceutical Inhaled Corticosteroid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Inhaled Corticosteroid Sales by Manufacturer (2018-2019) (M Units)
Table 86. Global Inhaled Corticosteroid Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Inhaled Corticosteroid Sales by Regions (2015-2020) (M Units)
Table 88. Global Inhaled Corticosteroid Sales Market Share by Regions (2015-2020)
Table 89. Global Inhaled Corticosteroid Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Inhaled Corticosteroid Sales by Countries (2015-2020) (M Units)
Table 91. North America Inhaled Corticosteroid Sales Market Share by Countries (2015-2020)
Table 92. North America Inhaled Corticosteroid Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Inhaled Corticosteroid Revenue Market Share by Countries (2015-2020)
Table 94. Europe Inhaled Corticosteroid Sales by Countries (2015-2020) (M Units)
Table 95. Europe Inhaled Corticosteroid Sales Market Share by Countries (2015-2020)
Table 96. Europe Inhaled Corticosteroid Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Inhaled Corticosteroid Sales by Regions (2015-2020) (M Units)
Table 98. Asia-Pacific Inhaled Corticosteroid Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Inhaled Corticosteroid Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Inhaled Corticosteroid Sales by Countries (2015-2020) (M Units)
Table 101. South America Inhaled Corticosteroid Sales Market Share by Countries (2015-2020)
Table 102. South America Inhaled Corticosteroid Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Inhaled Corticosteroid Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Inhaled Corticosteroid Sales by Countries (2015-2020) (M Units)
Table 105. Middle East & Africa Inhaled Corticosteroid Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Inhaled Corticosteroid Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Inhaled Corticosteroid Revenue Market Share by Countries (2015-2020)
Table 108. Global Inhaled Corticosteroid Sales by Type (2015-2020) (M Units)
Table 109. Global Inhaled Corticosteroid Sales Share by Type (2015-2020)
Table 110. Global Inhaled Corticosteroid Revenue by Type (2015-2020) (USD Million)
Table 111. Global Inhaled Corticosteroid Revenue Share by Type (2015-2020)
Table 112. Global Inhaled Corticosteroid Sales by Application (2015-2020) (M Units)
Table 113. Global Inhaled Corticosteroid Sales Share by Application (2015-2020)
Table 114. Global Inhaled Corticosteroid Sales Forecast by Regions (2021-2025) (M Units)
Table 115. Global Inhaled Corticosteroid Market Share Forecast by Regions (2021-2025)
Table 116. Global Inhaled Corticosteroid Sales Forecast by Type (2021-2025) (M Units)
Table 117. Global Inhaled Corticosteroid Market Share Forecast by Type (2021-2025)
Table 118. Global Inhaled Corticosteroid Sales Forecast by Application (2021-2025)
Table 119. Global Inhaled Corticosteroid Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Inhaled Corticosteroid Picture
Figure 2. Global Sales Market Share of Inhaled Corticosteroid by Type in 2019
Figure 3. Beclomethasone Dipropionate Picture
Figure 4. Budesonide Picture
Figure 5. Fluticasone Inhaler Powder Picture
Figure 6. Mometasone Picture
Figure 7. Others Picture
Figure 8. Inhaled Corticosteroid Sales Market Share by Application in 2018
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Respiratory Care Centers Picture
Figure 12. Others Picture
Figure 13. Global Inhaled Corticosteroid Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Inhaled Corticosteroid Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Inhaled Corticosteroid Sales Market Share by Manufacturer in 2019
Figure 34. Global Inhaled Corticosteroid Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Inhaled Corticosteroid Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Inhaled Corticosteroid Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 39. Global Inhaled Corticosteroid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Inhaled Corticosteroid Revenue Market Share by Regions (2015-2020)
Figure 41. Global Inhaled Corticosteroid Revenue Market Share by Regions in 2018
Figure 42. North America Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
Figure 43. Europe Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
Figure 45. South America Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Inhaled Corticosteroid Sales and Growth Rate (2015-2020)
Figure 47. North America Inhaled Corticosteroid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Inhaled Corticosteroid Sales Market Share by Countries (2015-2020)
Figure 49. North America Inhaled Corticosteroid Sales Market Share by Countries in 2018
Figure 50. North America Inhaled Corticosteroid Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Inhaled Corticosteroid Revenue Market Share by Countries in 2018
Figure 52. United States Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 53. Canada Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 54. Mexico Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 55. Europe Inhaled Corticosteroid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Inhaled Corticosteroid Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Inhaled Corticosteroid Revenue Market Share by Countries in 2019
Figure 58. Germany Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 59. UK Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 60. France Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 61. Russia Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 62. Italy Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 63. Asia-Pacific Inhaled Corticosteroid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Inhaled Corticosteroid Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Inhaled Corticosteroid Revenue Market Share by Regions 2019
Figure 66. China Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 67. Japan Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 68. Korea Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 69. India Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 70. Southeast Asia Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 71. South America Inhaled Corticosteroid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Inhaled Corticosteroid Sales Market Share by Countries in 2019
Figure 73. South America Inhaled Corticosteroid Revenue Market Share by Countries in 2019
Figure 74. Brazil Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 75. Argentina Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 76. Middle East and Africa Inhaled Corticosteroid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Inhaled Corticosteroid Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Inhaled Corticosteroid Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Inhaled Corticosteroid Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 81. Egypt Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 82. Turkey Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 83. South Africa Inhaled Corticosteroid Sales and Growth Rate (2015-2020) (M Units)
Figure 84. Global Inhaled Corticosteroid Sales and Growth Rate (2021-2025) (M Units)
Figure 85. Global Inhaled Corticosteroid Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Inhaled Corticosteroid Market Forecast (2021-2025) (M Units)
Figure 87. Europe Sales Inhaled Corticosteroid Market Forecast (2021-2025) (M Units)
Figure 88. Asia-Pacific Sales Inhaled Corticosteroid Market Forecast (2021-2025) (M Units)
Figure 89. South America Sales Inhaled Corticosteroid Market Forecast (2021-2025) (M Units)
Figure 90. Middle East & Africa Sales Inhaled Corticosteroid Market Forecast (2021-2025) (M Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
副腎皮質ステロイド阻害剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Adrenal Corticosteroid Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…- コルチコステロイド反応性皮膚病の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Corticosteroid-Responsive Dermatoses market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Corticos…
- 吸入抗生物質の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Inhaled Antibiotics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- スマート吸入器技術の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Smart Inhaler Technology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Smart Inhaler Techno…
- 下気道感染症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Lower Respiratory Tract Infection Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The L…